Ignite Creation Date:
2025-12-24 @ 11:02 PM
Ignite Modification Date:
2025-12-30 @ 12:49 AM
Study NCT ID:
NCT01003769
Status:
TERMINATED
Last Update Posted:
2020-06-16
First Post:
2009-10-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lenalidomide and AT-101 in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-09
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-14
Completion Date Type:
ACTUAL
First Submit Date:
2009-10-28
First Submit QC Date:
None
Study First Post Date:
2009-10-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-01-02
Results First Submit QC Date:
None
Results First Post Date:
2020-06-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-11
Last Update Post Date:
2020-06-16
Last Update Post Date Type:
ACTUAL